Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

AGEs and their receptors play a significant role in hair loss by causing inflammation and oxidative stress.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Eating a lot of fat increases PKCβ and inflammation in skin fat cells, which affects skin and hair health.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Targeting inflammation can improve scalp and hair health.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Melatonin may protect ear cells from damage caused by nicotine.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

High DHA levels delay wound healing and worsen skin repair quality.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Finasteride may slow down heart disease by lowering cholesterol and reducing inflammation.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.